MDLZ vs ROP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 16, 2026

MDLZ

44.9
AI Score
VS
MDLZ Wins

ROP

39.1
AI Score

Investment Advisor Scores

MDLZ

45score
Recommendation
HOLD

ROP

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDLZ ROP Winner
Revenue 10.08B 4.20B MDLZ
Net Income 560.00M 1.68B ROP
Gross Margin 27.8% 69.5% ROP
Net Margin 5.6% 39.9% ROP
Operating Income 808.00M 1.15B ROP
ROE 2.2% 9.0% ROP
ROA 0.8% 4.8% ROP
Total Assets 71.12B 35.17B MDLZ
Current Ratio 0.54 0.55 ROP

Relative Price Performance (Last 90 Days)

MDLZ 1M: -3.7% · 3M: +1.9% ROP 1M: -9.4% · 3M: +0.7%

Current Technical Phase

MDLZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.0 · Price: $59.38

ROP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.9 · Price: $358.57

Fundamentals Snapshot

Metric MDLZ ROP
Market Cap — —
Forward P/E 17.7 14.7
Trailing P/E 21.9 15.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.7%
Operating Margin 0.2% 0.3%
EPS 2.72 24.00
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, MDLZ is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.